We develop solid-state, totally absorbable solid implants TASI, and related technologies for cancers, pain control, etc. 4 key US patents approved in the exciting implantable extended-release technology field. Proof of concept tests is safe and effective with rodent models. Two prototype drug implants are ready for preclinical trial, thanks to a breakthrough technology. Ultimate goal is FDA approval of TASI implants for human prostate cancer, and acute/chronic pain market.